JACQUELINE JOLLOTA: Open Payments
NPI 1366159741 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,309 in 64 payments from 19 companies in 2025. Trend: 2023 $277 · 2024 $873 · 2025 $2,309
Food & beverage: $2,309
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 2 | $319 |
| Incyte Corporation | 14 | $307 |
| Galderma Laboratories, L.P. | 4 | $228 |
| Janssen Biotech, Inc. | 7 | $224 |
| Organon LLC | 3 | $220 |
| UCB, Inc. | 5 | $189 |
| GENZYME CORPORATION | 4 | $162 |
| Organogenesis Inc. | 1 | $127 |
| Lilly USA, LLC | 4 | $99 |
| Amgen Inc. | 4 | $89 |
Products named: Xeomin, OPZELURA, TREMFYA, NEMLUVIO, VTAMA, Bimzelx, DUPIXENT, CYGNUS DUAL.
Industry payments across CA — which companies pay providers there.
